Literature DB >> 22433665

Dementia diagnosis differs in men and women and depends on age and dementia severity: data from SveDem, the Swedish Dementia Quality Registry.

Dorota Religa1, Kalle Spångberg, Anders Wimo, Ann-Katrin Edlund, Bengt Winblad, Maria Eriksdotter-Jönhagen.   

Abstract

AIMS: We examine the dementia assessment with focus on age and gender differences.
METHODS: Data from the national quality database, Swedish Dementia Registry (SveDem), including 6,937 dementia patients diagnosed during 2007-2009 at memory clinics were used. We have studied the use of investigations for dementia diagnostics such as cognitive tests, blood and cerebrospinal fluid analyses, electroencephalography, radiological examinations and assessments of functions. Severity of cognitive impairment was assessed with the Mini Mental State Examination (MMSE).
RESULTS: There was a significant decrease in the number of total tests used in the elderly group (>75 years) when compared with the middle-aged group (65-75 years) and younger patients (<65 years). The oldest group was examined with 4 of 11 possible tests, the middle-aged group had 5/11 tests performed and the youngest age group 6/11 tests. There was also a significant gender difference in the diagnostic workup, however, mostly attributable to age. The number of tests positively correlated with the level of cognition assessed by the MMSE.
CONCLUSION: We show here for the first time the impact of age, gender and MMSE score on the dementia diagnostic workup in a large memory clinic patient population in one country.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22433665     DOI: 10.1159/000337038

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  17 in total

1.  Anti-dementia drugs and co-medication among patients with Alzheimer's disease : investigating real-world drug use in clinical practice using the Swedish Dementia Quality Registry (SveDem).

Authors:  Seyed-Mohammad Fereshtehnejad; Kristina Johnell; Maria Eriksdotter
Journal:  Drugs Aging       Date:  2014-03       Impact factor: 3.923

Review 2.  2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.

Authors:  A Leuzy; N J Ashton; N Mattsson-Carlgren; A Dodich; M Boccardi; J Corre; A Drzezga; A Nordberg; R Ossenkoppele; H Zetterberg; K Blennow; G B Frisoni; V Garibotto; O Hansson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-05       Impact factor: 9.236

3.  Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) study.

Authors:  Anna-Maija Tolppanen; Heidi Taipale; Marjaana Koponen; Piia Lavikainen; Antti Tanskanen; Jari Tiihonen; Sirpa Hartikainen
Journal:  Clin Epidemiol       Date:  2013-08-07       Impact factor: 4.790

4.  Body Mass Index in Different Dementia Disorders: Results from the Swedish Dementia Quality Registry (SveDem).

Authors:  Gerd Faxén-Irving; Seyed-Mohammad Fereshtehnejad; Farshad Falahati; Lars Cedergren; Helen Göranzon; Kristine Wallman; Sara García-Ptacek; Maria Eriksdotter; Dorota Religa
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-04-03

5.  SveDem, the Swedish Dementia Registry - a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice.

Authors:  Dorota Religa; Seyed-Mohammad Fereshtehnejad; Pavla Cermakova; Ann-Katrin Edlund; Sara Garcia-Ptacek; Nicklas Granqvist; Anne Hallbäck; Kerstin Kåwe; Bahman Farahmand; Lena Kilander; Ulla-Britt Mattsson; Katarina Nägga; Peter Nordström; Helle Wijk; Anders Wimo; Bengt Winblad; Maria Eriksdotter
Journal:  PLoS One       Date:  2015-02-19       Impact factor: 3.240

6.  Comorbidity profile in dementia with Lewy bodies versus Alzheimer's disease: a linkage study between the Swedish Dementia Registry and the Swedish National Patient Registry.

Authors:  Seyed-Mohammad Fereshtehnejad; Soheil Damangir; Pavla Cermakova; Dag Aarsland; Maria Eriksdotter; Dorota Religa
Journal:  Alzheimers Res Ther       Date:  2014-10-06       Impact factor: 6.982

7.  Heart failure and dementia: survival in relation to types of heart failure and different dementia disorders.

Authors:  Pavla Cermakova; Lars H Lund; Seyed-Mohammad Fereshtehnejad; Kristina Johnell; Bengt Winblad; Ulf Dahlström; Maria Eriksdotter; Dorota Religa
Journal:  Eur J Heart Fail       Date:  2015-01-10       Impact factor: 15.534

8.  The societal costs of dementia in Sweden 2012 - relevance and methodological challenges in valuing informal care.

Authors:  Anders Wimo; Linus Jönsson; Laura Fratiglioni; Per Olof Sandman; Anders Gustavsson; Anders Sköldunger; Lennarth Johansson
Journal:  Alzheimers Res Ther       Date:  2016-11-18       Impact factor: 6.982

9.  Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem).

Authors:  Seyed-Mohammad Fereshtehnejad; Dorota Religa; Eric Westman; Dag Aarsland; Johan Lökk; Maria Eriksdotter
Journal:  Neuropsychiatr Dis Treat       Date:  2013-06-28       Impact factor: 2.570

10.  Age-related incidence and family history in frontotemporal dementia: data from the Swedish Dementia Registry.

Authors:  Christer Nilsson; Maria Landqvist Waldö; Karin Nilsson; Alexander Santillo; Susanna Vestberg
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.